Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-173-20513646
Mobile: 17320513646
Tel: +86-173-20513646
Fax:
Province/state: Hu Bei
City: Wuhan
Street: Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
MaxCard:
CAS NO.1691223-83-2
1(10--1)Metric Ton
We supply over 20000 types of spot impurity reference materials, with sufficient supply and same day delivery to meet customers' urgent needs for replenishment at any time. The company has its own research and development center and laboratory, and the team members have over ten years of experience in developing drug impurity reference standards. Our website www.molcoo.com covers over 98% of cutting-edge generic drug projects, with complete structural formulas that greatly save customers time in impurity structure analysis and inference. All products undergo strict quality control testing and provide relevant information such as COA, H-NMR, C-NMR, MS/GC-MS, HPLC/GC purity, QNMR quantification, TGA thermogravimetric analysis, IR infrared, UV ultraviolet, two-dimensional (COSY, NOESY, HMBC, HMQC), etc. These structural confirmation spectra ensure quality and reliability. Our products have a wide range of categories, fast delivery time, good quality, and low prices, which can quickly solve various customer needs such as replenishment and consistency evaluation.
Sunitinib Impurity Reference Standards
Sunitinib impurity reference standards serve as crucial tools in drug research and development, quality control, and impurity analysis. These reference standards encompass a wide range of impurities that may be present in sunitinib drugs, including but not limited to Sunitinib Impurity B, Sunitinib Ketone Impurity, Sunitinib N-Oxide, Sunitinib Impurity C, and Sunitinib Impurity G (N,N-Didesethyl Sunitinib HCl). These reference standards exhibit high purity, stability, and sensitivity, which are essential for accurately identifying and quantifying the impurity content in drugs.
By utilizing sunitinib impurity reference standards, drug researchers and quality control personnel can ensure the safety and effectiveness of drugs, preventing impurities from adversely affecting drug efficacy and safety. Furthermore, these reference standards can be used to optimize drug production processes, improve drug purity and stability, and reduce production costs.
Our sunitinib impurity reference standards undergo rigorous quality control to meet the requirements of international pharmacopoeias and relevant regulations. We are committed to providing high-quality, diverse impurity reference standards to meet the needs of different drug research and production processes.